Wide Ranks

ETON

Eton Pharmaceuticals, Inc.

12.74

Top Statistics
Market Cap 329 M Forward PE 30.33 Revenue Growth -24.40 %
Current Ratio 1.40 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -21.31 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -49.12 Enterprise / Revenue 8.32 Price To Sales Trailing12 Months 10.49
Profitability
Profit Margins -21.31 % Operating Margins -32.34 %
Balance Sheet
Total Cash 17 M Total Cash Per Share 0.6850 Total Debt 4 M
Total Debt To Equity 36.23 Current Ratio 1.40 Book Value Per Share 0.6020
All Measures
Short Ratio 93.00 % Message Board Id finmb_435353222 Shares Short Prior Month 126337
Return On Equity -0.4430 City Deer Park Uuid fbcd977f-686a-3d1e-ae47-b3ae800e35f4
Previous Close 12.45 First Trade Date Epoch Utc 1 B Book Value 0.6020
Beta 1.26 Total Debt 4 M Volume 186560
Price To Book 21.16 Fifty Two Week Low 3.03 Total Cash Per Share 0.6850
Total Revenue 31 M Shares Short Previous Month Date 1 B Target Median Price 15.00
Max Age 86400 Recommendation Mean 1.50 Sand P52 Week Change 0.3133
Operating Margins -32.34 % Target Mean Price 15.00 Net Income To Common -6687000
Short Percent Of Float 0.0078 Implied Shares Outstanding 25 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 320020 Average Volume10days 320020
Total Cash 17 M Next Fiscal Year End 1 B Revenue Per Share 1.22
Held Percent Insiders 0.0539 Ebitda Margins -16.93 % Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 12.45
Target Low Price 15.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 8.37
Open 12.49 Free Cashflow -380250 State IL
Dividend Yield 0.00 % Return On Assets -0.1250 Time Zone Short Name EST
Trailing Eps -0.2100 Day Low 12.15 Address1 21925 W. Field Parkway
Shares Outstanding 25 M Price Hint 2 Target High Price 15.00
Website https://www.etonpharma.com 52 Week Change 2.60 Average Volume 203839
Forward Eps 0.5300 Recommendation Key strong_buy Compensation As Of Epoch Date 1 B
Quick Ratio 123.90 % Is_sp_500 False Regular Market Day High 12.77
Profit Margins -21.31 % Debt To Equity 36.23 Fifty Two Week High 12.77
Day High 12.77 Shares Short 191937 Regular Market Open 12.49
Industry Key drug-manufacturers-specialty-generic Earnings Growth 0.00 % Enterprise To Revenue 8.32
Revenue Growth -24.40 % Shares Percent Shares Out 0.0074 Operating Cashflow 42000
Currency USD Time Zone Full Name America/New_York Market Cap 329 M
Is_nasdaq_100 False Zip 60010-7278 Quote Type EQUITY
Industry Drug Manufacturers - Specialty & Generic Long Name Eton Pharmaceuticals, Inc. Regular Market Day Low 12.15
Held Percent Institutions 0.3336 Current Price 12.74 Address2 Suite 235
Enterprise To Ebitda -49.12 Financial Currency USD Current Ratio 1.40
Gross Margins 59.48 % Industry Disp Drug Manufacturers - Specialty & Generic Number Of Analyst Opinions 2
Country United States Float Shares 21 M Two Hundred Day Average 4.97
Enterprise Value 261 M Price To Sales Trailing12 Months 10.49 Forward PE 30.33
Regular Market Volume 186560 Ebitda -5314000 Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases.

The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1.

It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis.

Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.